Pediatrix Medical Group, Inc.
MDPediatrix Medical Group, Inc. (MD) is a healthcare company specializing in neonatal and pediatric subspecialty care. Founded in 1996, it provides both hospital-based and office-based services, including neonatal fetal and maternal care, pediatric cardiology, and other subspecialties. The company partners with hospitals and healthcare providers to deliver high-quality medical services for infants and children.
Company News
ARS Pharmaceuticals reported $32.5 million in revenue for Q3 2025, primarily from neffy epinephrine nasal spray sales. The company continues to expand market presence through direct-to-consumer campaigns and has strong cash reserves of $288.2 million.
Pediatrix Medical Group reported strong Q2 2025 earnings, with non-GAAP EPS of $0.53 beating analyst expectations. Despite a 7.4% revenue decline due to practice divestitures, the company showed growth in hospital-based neonatal services and raised its adjusted EBITDA guidance.
MONTRÉAL, 25 juin 2024 (GLOBE NEWSWIRE) -- Exploration Midland inc. (« Midland ») (TSX-V: MD), en partenariat avec Probe Gold Inc. (« Probe »), a le plaisir d’annoncer la reprise des travaux d’exploration sur la découverte d’un système minéralisé en cuivre-or-argent-molybdène (« Cu-Au-Ag-Mo ») effectuée en 2022 sur la pro...
MONTREAL, June 25, 2024 (GLOBE NEWSWIRE) -- Midland Exploration Inc. (“Midland”) (TSX-V: MD), in partnership with Probe Gold Inc. (“Probe”), is pleased to announce that exploration work will resume on the copper-gold-silver-molybdenum (“Cu-Au-Ag-Mo”) discovery made in 2022 on the La Peltrie Option (the “Property”). This signifi...
Investors need to pay close attention to Pediatrix Medical (MD) stock based on the movements in the options market lately.
